Officials at AstraZeneca report that their new medication, elecoglipron, helped people with type 2 diabetes reduce blood glucose levels and lose 10.5% of their body weight at 26 weeks
Yes, you can still lose weight
GHK-Cu provides the matrix component (the scaffolding of the tissue itself)
In the first study, we evaluated the effect of the analogues on the blood glucose concentration of normal mice (Fig
Weight Loss Adherence (12 mo) Total Value Consideration GLP-1 (unmonitored) $10,000$13,000 1015% ~5060% dropout High drug waste GLP-1 (with monitoring) $10,000 + $60 (monitoring) 1015% ~75% persistence ROI-positive (saves $3k+ per patient) SGLT2 inhibitor $6,000$7,000 23% ~70% Lower cost, but modest outcomes Older anti-obesity meds $500$2,000 35% ~4050% Low efficacy, poor tolerability --- 3
They do not grant supernatural regeneration powers